Want to join the conversation?
$DCT said Thomas Wattles will be appointed as Chairman Emeritus and will not stand for re-election to $DCT's BoD at Annual meeting on May 4, 2016. Wattles will remain on $DCT's Executive and Internal Investment Committees. Upon his re-election as director, Thomas August will be appointed as Chairman, immediately following its Annual Meeting.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?